Source: REUTERS, 10/4/21

 Johnson & Johnson (JNJ.N) is planning to ask U.S. federal regulators this week to authorize a booster shot of its COVID-19 vaccine, the New York Times reported on Monday, citing officials familiar with the company's plans. While scientists are divided over the need for booster shots when so many people in the United States and other countries remain unvaccinated, the Biden administration announced the push for an extra dose in August as part of an effort to shore up protection against the highly transmissible Delta variant. read more

For more of this story, click here.